KR20220107330A - Dp 길항제 - Google Patents
Dp 길항제 Download PDFInfo
- Publication number
- KR20220107330A KR20220107330A KR1020227025551A KR20227025551A KR20220107330A KR 20220107330 A KR20220107330 A KR 20220107330A KR 1020227025551 A KR1020227025551 A KR 1020227025551A KR 20227025551 A KR20227025551 A KR 20227025551A KR 20220107330 A KR20220107330 A KR 20220107330A
- Authority
- KR
- South Korea
- Prior art keywords
- phenyl
- chloro
- halogen atom
- atom
- acetic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/56—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/64—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/48—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Auxiliary Devices For Music (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018175758 | 2018-09-20 | ||
| JPJP-P-2018-175758 | 2018-09-20 | ||
| PCT/JP2019/036725 WO2020059790A1 (ja) | 2018-09-20 | 2019-09-19 | Dpアンタゴニスト |
| KR1020217008017A KR102425709B1 (ko) | 2018-09-20 | 2019-09-19 | Dp 길항제 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020217008017A Division KR102425709B1 (ko) | 2018-09-20 | 2019-09-19 | Dp 길항제 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20220107330A true KR20220107330A (ko) | 2022-08-02 |
Family
ID=69888481
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020227025551A Withdrawn KR20220107330A (ko) | 2018-09-20 | 2019-09-19 | Dp 길항제 |
| KR1020217008017A Active KR102425709B1 (ko) | 2018-09-20 | 2019-09-19 | Dp 길항제 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020217008017A Active KR102425709B1 (ko) | 2018-09-20 | 2019-09-19 | Dp 길항제 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US11319296B2 (enExample) |
| EP (1) | EP3854781B1 (enExample) |
| JP (2) | JP7021709B2 (enExample) |
| KR (2) | KR20220107330A (enExample) |
| CN (1) | CN112739680A (enExample) |
| AU (1) | AU2019341082A1 (enExample) |
| BR (1) | BR112021005260A2 (enExample) |
| CA (1) | CA3113210A1 (enExample) |
| ES (1) | ES2982217T3 (enExample) |
| IL (2) | IL310383A (enExample) |
| MX (1) | MX2021003131A (enExample) |
| NZ (1) | NZ774113A (enExample) |
| PH (1) | PH12021550549A1 (enExample) |
| SG (1) | SG11202102566YA (enExample) |
| TW (2) | TWI784199B (enExample) |
| WO (1) | WO2020059790A1 (enExample) |
| ZA (1) | ZA202101887B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11319296B2 (en) * | 2018-09-20 | 2022-05-03 | Ono Pharmaceutical Co., Ltd. | DP antagonist |
| TW202146394A (zh) * | 2020-03-19 | 2021-12-16 | 日商小野藥品工業股份有限公司 | 苯乙酸化合物之結晶 |
| JP2024016311A (ja) * | 2020-12-24 | 2024-02-07 | 小野薬品工業株式会社 | Ep2アンタゴニスト |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003078409A1 (en) | 2002-03-19 | 2003-09-25 | Ono Pharmaceutical Co., Ltd. | Carboxyoic acid compounds and drugs containing the compounds as the active ingredient |
| WO2005028455A1 (ja) | 2003-09-17 | 2005-03-31 | Ono Pharmaceutical Co., Ltd. | カルボン酸化合物およびそれらを有効成分として含有する医薬組成物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4994479A (en) * | 1985-04-03 | 1991-02-19 | Yamanouchi Pharmaceutical Co., Ltd. | Phenylene derivatives and anti-allergic use thereof |
| JPS63159342A (ja) * | 1985-04-03 | 1988-07-02 | Yamanouchi Pharmaceut Co Ltd | 新規カルボン酸化合物 |
| EP1723132A1 (en) * | 2004-02-12 | 2006-11-22 | Asterand Uk Limited | Ep2 receptor agonists |
| US7803786B2 (en) | 2004-06-17 | 2010-09-28 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions and related methods of use |
| TWI410410B (zh) * | 2007-08-10 | 2013-10-01 | Ono Pharmaceutical Co | Phenylacetic acid compounds |
| CA2849350A1 (en) | 2011-09-26 | 2013-04-04 | Grunenthal Gmbh | Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands |
| JP2020502189A (ja) | 2016-12-20 | 2020-01-23 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | インドールアミン2,3−ジオキシゲナーゼのモジュレーター |
| JP6533249B2 (ja) | 2017-04-21 | 2019-06-19 | 山佐株式会社 | 遊技機用基板ケースの取り付け構造及び遊技機 |
| CN110785408A (zh) | 2017-06-28 | 2020-02-11 | 葛兰素史克知识产权开发有限公司 | 吲哚胺2,3-双加氧酶的调节剂 |
| US11319296B2 (en) | 2018-09-20 | 2022-05-03 | Ono Pharmaceutical Co., Ltd. | DP antagonist |
-
2019
- 2019-09-19 US US17/276,284 patent/US11319296B2/en active Active
- 2019-09-19 BR BR112021005260-7A patent/BR112021005260A2/pt not_active Application Discontinuation
- 2019-09-19 ES ES19862361T patent/ES2982217T3/es active Active
- 2019-09-19 KR KR1020227025551A patent/KR20220107330A/ko not_active Withdrawn
- 2019-09-19 IL IL310383A patent/IL310383A/en unknown
- 2019-09-19 JP JP2020548589A patent/JP7021709B2/ja active Active
- 2019-09-19 AU AU2019341082A patent/AU2019341082A1/en not_active Abandoned
- 2019-09-19 NZ NZ774113A patent/NZ774113A/en unknown
- 2019-09-19 SG SG11202102566YA patent/SG11202102566YA/en unknown
- 2019-09-19 CA CA3113210A patent/CA3113210A1/en active Pending
- 2019-09-19 KR KR1020217008017A patent/KR102425709B1/ko active Active
- 2019-09-19 TW TW108133822A patent/TWI784199B/zh not_active IP Right Cessation
- 2019-09-19 MX MX2021003131A patent/MX2021003131A/es unknown
- 2019-09-19 WO PCT/JP2019/036725 patent/WO2020059790A1/ja not_active Ceased
- 2019-09-19 TW TW111143026A patent/TWI822457B/zh active
- 2019-09-19 EP EP19862361.3A patent/EP3854781B1/en active Active
- 2019-09-19 CN CN201980061636.8A patent/CN112739680A/zh active Pending
-
2021
- 2021-03-11 IL IL281433A patent/IL281433A/en unknown
- 2021-03-12 PH PH12021550549A patent/PH12021550549A1/en unknown
- 2021-03-19 ZA ZA2021/01887A patent/ZA202101887B/en unknown
-
2022
- 2022-01-13 JP JP2022003838A patent/JP7338711B2/ja active Active
- 2022-03-15 US US17/695,796 patent/US20220204468A1/en not_active Abandoned
-
2024
- 2024-10-14 US US18/915,276 patent/US20250042870A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003078409A1 (en) | 2002-03-19 | 2003-09-25 | Ono Pharmaceutical Co., Ltd. | Carboxyoic acid compounds and drugs containing the compounds as the active ingredient |
| WO2005028455A1 (ja) | 2003-09-17 | 2005-03-31 | Ono Pharmaceutical Co., Ltd. | カルボン酸化合物およびそれらを有効成分として含有する医薬組成物 |
Non-Patent Citations (12)
| Title |
|---|
| [비특허문헌 1] 더 뉴 잉글랜드 저널 오브 메디슨(The NEW ENGLAND JOURNAL of MEDICINENE), Vol. 303, 1400-1404, 1980 |
| [비특허문헌 10] 더 저널 오브 알레르기 앤드 클리니컬 이뮤놀로지(The Journal of Allergy and Clinical Immunology), Vol. 87, 540-548, 1991 |
| [비특허문헌 11] 더 저널 오브 알레르기 앤드 클리니컬 이뮤놀로지(The Journal of Allergy and Clinical Immunology), Vol. 78, 458-461, 1986 |
| [비특허문헌 12] 프로시딩스 오브 더 내셔널 아카데미 오브 사이엔시즈 오브 더 유나이티드 스테이츠 오브 아메리카(Proceedings of the National Academy of Sciences of the United States of America), Vol. 98, 11674-11679, 2001 |
| [비특허문헌 2] 아메리칸 리뷰 오브 레스퍼레토리 디지즈(American Review of Respiratory Disease), Vol. 128, 597-602, 1983 |
| [비특허문헌 3] 더 저널 오브 알레르기 앤드 클리니컬 이뮤놀로지(The Journal of Allergy and Clinical Immunology), Vol. 88, 33-42, 1991 |
| [비특허문헌 4] 아카이브스 오브 오토라린골로지-헤드 앤드 넥 서저리(Archives of Otolaryngology-Head and Neck Surgery), Vol. 113, 179-83, 1987 |
| [비특허문헌 5] 더 저널 오브 알레르기 앤드 클리니컬 이뮤놀로지(The Journal of Allergy and Clinical Immunology), Vol. 82, 869-77, 1988 |
| [비특허문헌 6] 더 저널 오브 이뮤놀로지(The Journal of Immunology), Vol. 146, 671-676, 1991 |
| [비특허문헌 7] 더 저널 오브 알레르기 앤드 클리니컬 이뮤놀로지(The Journal of Allergy and Clinical Immunology), Vol. 83, 905-912, 1989 |
| [비특허문헌 8] 더 뉴 잉글랜드 저널 오브 메디슨(The NEW ENGLAND JOURNAL of MEDICINENE), Vol. 315, 800-804, 1986 |
| [비특허문헌 9] 아메리칸 리뷰 오브 레스퍼레토리 디지즈(American Review of Respiratory Disease), Vol. 142, 126-132, 1990 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR102425709B1 (ko) | 2022-07-28 |
| US20250042870A1 (en) | 2025-02-06 |
| IL281433A (en) | 2021-04-29 |
| JPWO2020059790A1 (ja) | 2021-09-02 |
| EP3854781B1 (en) | 2024-05-22 |
| WO2020059790A1 (ja) | 2020-03-26 |
| TWI784199B (zh) | 2022-11-21 |
| AU2019341082A1 (en) | 2021-04-15 |
| EP3854781A1 (en) | 2021-07-28 |
| JP2022058610A (ja) | 2022-04-12 |
| TWI822457B (zh) | 2023-11-11 |
| US20220204468A1 (en) | 2022-06-30 |
| JP7338711B2 (ja) | 2023-09-05 |
| US11319296B2 (en) | 2022-05-03 |
| MX2021003131A (es) | 2021-05-14 |
| ZA202101887B (en) | 2022-10-26 |
| JP7021709B2 (ja) | 2022-02-17 |
| TW202308986A (zh) | 2023-03-01 |
| CA3113210A1 (en) | 2020-03-26 |
| NZ774113A (en) | 2024-09-27 |
| US20220033371A1 (en) | 2022-02-03 |
| IL310383A (en) | 2024-03-01 |
| EP3854781A4 (en) | 2022-02-23 |
| TW202023535A (zh) | 2020-07-01 |
| PH12021550549A1 (en) | 2022-02-14 |
| KR20210065944A (ko) | 2021-06-04 |
| ES2982217T3 (es) | 2024-10-15 |
| CN112739680A (zh) | 2021-04-30 |
| SG11202102566YA (en) | 2021-04-29 |
| BR112021005260A2 (pt) | 2021-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7338711B2 (ja) | Dpアンタゴニスト | |
| AU2015336458B2 (en) | KCNQ2-5 channel activator | |
| JP7750341B2 (ja) | Abhd6アンタゴニスト | |
| WO2020262603A1 (ja) | Ep2アンタゴニスト | |
| JP6197971B1 (ja) | Kcnq2〜5チャネル関連疾患の予防および/または治療剤 | |
| RU2803243C2 (ru) | Антагонист dp | |
| JP7047954B2 (ja) | フェニル酢酸化合物を含有する医薬組成物 | |
| HK40051095A (en) | Dp antagonist | |
| AU2023352529A1 (en) | Abhd6 antagonist | |
| JP2024052624A (ja) | Abhd6アンタゴニストを含有する医薬組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A107 | Divisional application of patent | ||
| PA0104 | Divisional application for international application |
St.27 status event code: A-0-1-A10-A16-div-PA0104 St.27 status event code: A-0-1-A10-A18-div-PA0104 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| PC1202 | Submission of document of withdrawal before decision of registration |
St.27 status event code: N-1-6-B10-B11-nap-PC1202 |